Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment
about
The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity.TOTAL-BODY PET: MAXIMIZING SENSITIVITY TO CREATE NEW OPPORTUNITIES FOR CLINICAL RESEARCH AND PATIENT CARE.Uniform intratumoral distribution of radioactivity produced using two different radioagents, 64Cu-cyclam-RAFT-c(-RGDfK-)4 and 64Cu-ATSM, improves therapeutic efficacy in a small animal tumor model.
P2860
Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment
@en
type
label
Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment
@en
prefLabel
Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment
@en
P2860
P356
P1476
Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment
@en
P2093
Hossein Jadvar
P2860
P304
P356
10.2214/AJR.17.18264
P407
P577
2017-05-02T00:00:00Z